Join to View Full Profile
11300 Ridge Mist TerPotomac, MD 20854
Phone+1 240-599-4500
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mihael Polymeropoulos, MD is a psychiatrist in Potomac, Maryland. He is currently licensed to practice medicine in Maryland and District of Columbia.
Education & Training
Clinical Center at the National Institutes of HealthFellowship, Psychosomatic Medicine, 1988 - 1989
Saint Elizabeths Hospital-DC Department of Behavioral HealthResidency, Psychiatry, 1985 - 1988- University of Patras School of MedicineClass of 1983
Certifications & Licensure
MD State Medical License 1997 - 2025
DC State Medical License 1987 - 2002
Publications & Presentations
PubMed
- 4 citationsThe Efficacy of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Phase 3 Randomized Placebo-Controlled Clinical Trial.Jesse L Carlin, Christos Polymeropoulos, Michael Camilleri, Anthony Lembo, Michaela Fisher
Clinical Gastroenterology and Hepatology. 2024-12-01 - Tradipitant Effective in the Reduction of Vomiting Associated with Motion Sickness Across Varied Sea Conditions (S3.003).Vasilios Polymeropoulos, Margaret Bushman, Dane Morgan, Elizabeth Sutherland, Tanner Davis
Neurology. 2024-04-09 - 1 citationsEfficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study.Rosarelis Torres, Emily L Czeisler, Sean R Chadwick, Stephen M Stahl, Sandra P Smieszek
The Journal of Clinical Psychiatry. 2024-01-15
Press Mentions
Vanda Pharmaceuticals Announces the Publication of an Article Titled “Potential ASO-Based Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S”February 24th, 2025- Vanda Pharmaceuticals Reports Results from the Phase III Study of Tradipitant in GastroparesisFebruary 3rd, 2022
- Vanda Pharmaceuticals Reports Second Quarter 2021 Financial ResultsJuly 28th, 2021
- Join now to see all
